today show semaglutide A major new study in the New England Journal of Medicine compares two powerful weight-loss drugs: tirzepatide (Zepbound, Mounjaro) and (Wegovy, Ozempic). Both medications are GLP-1 Ozempic Slows Kidney Disease, Novo

Ozempic is strictly for type 2 diabetes control, whereas Wegovy is specifically tailored for weight loss

It mimics the action of the naturally occurring GLP-1 hormone, which stimulates insulin secretion in response to meals, suppresses glucagon release, and slows gastric emptying

Why Some Patients Do Not Respond to GLP-1 Therapies Kanwal Fatima, PharmD, BCMAS Ron Panarotti Emerging evidence suggests that some individuals develop nutritional deficiencies during treatment, whereas others experience biologically driven GLP-1 resistance

Heallys online platform offers fast, convenient consultations to assess eligibility and issue prescriptions no in-person visit required

T.McGeerE.McGeerP

The report uncovered several concerning facts: The FDA and U.S